Synthesis and antihyperlipidemic activity of some novel condensed 2-chloroalkyl-4-chloro/hydroxy-5,6-disubstituted pyrimidines

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 9, 2007, Pages 599-606

  Kathiravan, Matthu K ^a   Shishoo, Chamanlal J ^b   Kumar, Krishnan Girish ^a   Roy, Saroj Kumar ^a   Mahadik, Kakasheb R ^a   Kadam, Shivajirao S ^a   Jain, Kishor S ^c  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b L M COLLEGE OF PHARMACY   (India)

^c SINHGAD COLLEGE OF PHARMACY   (India)

Author keywords

Antihyperlipidemic drugs; Cholesterol; Hyperlipidemia; Thienopyrimidines, antihyperlipidemic activity, synthesis; Triglycerides; Triton

Indexed keywords

2 CHLOROALKYL 4 CHLORO 5,6 PYRIMIDINE DERIVATIVE; 2 CHLOROALKYL 4 HYDROXY 5,6 PYRIMIDINE DERIVATIVE; GEMFIBROZIL; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 35048872770     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296655     Document Type: Article

References (18)

1. Sudhop T, von Bergmann K. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Drugs. 2002;62:2333-2347.
2. Bruckert E. New advances in lipid-modifying therapies for reducing cardiovascular risk. Cardiology. 2002;97:59-66.
3. American Heart Association. Heart Disease and Stroke. Statistics-2003. www.americanheart.org/statistics.
4. Bays H. Ezetimibe. Expert Opin. Investig. Drugs. 2002;11:1587-1604.
5. Turley SD, Dietschy JM. Sterol absorption by the small intestine. Curr. Opin. Lipidol. 2003;14:233-240.
6. Clader JW, Burnett DA, Caplen MA, Domalski MS, Dugar S, Vaccaro W, et al. 2-Azetidinone cholesterol absorption inhibitors: Structure activity relationships on the heterocyclic nucleus. J. Med. Chem. 1996;39:3684-3693.
7. Shishoo CJ, Devani MB, Bhadti VS, Jain KS, Rathod IS, Goyal RK, et al. Synthesis and pharmacological study of antihyperlipaemic activity of 2-substituted thieno(2,3-d) pyridimin-4(3H)-ones. Arzneimittel-Forschung (Drug Research). 1990;40: 567-572.
8. Shishoo CJ, Devani MB, Bhadti VS. Indian Pat. 1981, 151, 496; Chem. Abstr. 1984;100:209858.
9. Shishoo CJ, Gandhi TR, Rathod IS, Jain KS, Goyal RK. Mechanism of the antihyperlipaemic activity and pharmacokinetics of 2-chloromethyl-5,6,7,8- tetrahydrobenzo(b)thieno [2,3-d]pyrimidin-4(3H)-one. Arzneimittel-Forschung (Drug Research). 1997;47:1125-1129.
10. Shishoo CJ, Jain KS, Rathod IS, Thakkar BJ, Brahmbhatt SB, Gandhi TP, et al. Synthesis and quantitative structure activity relationships of antihyperlipaemic 2-substituted thieno(3,2-d)pyrimidin-4(3H)-ones. Arzneimittel-Forschung (Drug Research). 1996;46:273-276.
11. Chrysselis MC, Rekka EA, Kourounakis PN. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity. J Med Chem. 2000;43:609-612.
12. Friedman M, Byers SO. Mechanism underlying hypercholesteremia induced by Triton. Am J Physiol. 1957;190(3):439-445.
13. Naik SR, D'Mello PM, Panwala PT. Antihyperlipidemic and antioxidant activity of Syzygium cumini. Indian Drugs. 2004;41:345-350.
14. Gewald K, Schinke E, Bottcher H. 2-Amino-thiophene aus Methylen-aktiven Nitrilen, Carbonylverbindungen und Schwefel. Chem Ber. 1966;99:94-99. Chem Abstr. 1966;64:8118.
15. Shishoo CJ, Devani MB, Pathak US, Ananthan S, Bhadti, VS, Jain KS, et al. Reaction of nitriles under acidic conditions. Part III: A facile synthesis of thienopyrimidin-4(3H)-ones. J Heterocycl Chem. 1984;21:375-380.
16. Reisner DB, Horning EC. Chloroacetonitrile. In: Rabjohn N, ed. Organic Syntheses Collective Volume 4. 2nd ed. New York: John Wiley & Sons; 1963. p 144-145.
17. George T, Mehta DV, Tahilramani, R. Synthesis of 3-amino-2- ethoxycarbonyl-4-quinazolone and related compounds: Part I - Use of diethyl oxalate in quinazolone synthesis. Indian J Chem. 1971;9B:755-758.
18. Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med. 1998;104(2A):14S-18S.